{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:01:58Z","timestamp":1792065718893,"version":"4.4.0"},"reference-count":45,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T00:00:00Z","timestamp":1480982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["26460996"],"award-info":[{"award-number":["26460996"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background &amp; Aims<\/jats:title><jats:p>Primary biliary cholangitis (<jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content>) is an autoimmune liver disease characterized by portal inflammation and immune\u2010mediated destruction of intrahepatic bile ducts that often leads to liver decompensation and liver failure. Although the biochemical response to ursodeoxycholic acid (<jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content>) can predict disease outcome in <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content>, few biomarkers have been identified as prognostic tools applicable prior to <jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content> treatment. We therefore sought to identify such indicators of long\u2010term outcome in <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> in the Japanese population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The prebiopsy serum samples and subsequent clinical data of 136 patients with <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content> treated with <jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content> were analysed over a median follow\u2010up period of 8.8\u00a0years. Serum levels of biomarkers related to microbial translocation (<jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>14, Endo<jats:styled-content style=\"fixed-case\">CA<\/jats:styled-content>b and I\u2010<jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>) were measured along with those of 33 cytokines and chemokines and additional auto\u2010antibodies. Associations between the tested parameters and the clinical outcomes of liver decompensation and liver\u2010related death\/liver transplantation were evaluated using the Cox proportional hazards model with stepwise methods and Kaplan\u2010Meier analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Elevated levels of serum <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108, and <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>14 before <jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content> therapy were significantly associated with both liver decompensation and liver\u2010related death\/liver transplantation. In multivariate analyses, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108\u226546.5\u00a0pg\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content> or <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>14\u22652.0\u00a0\u03bcg\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content> at enrolment demonstrated the same results. Kaplan\u2010Meier analysis also revealed <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108 and <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>14 to be significantly associated with a poor outcome. <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>14 was significantly correlated with <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108. Endo<jats:styled-content style=\"fixed-case\">CA<\/jats:styled-content>b and I\u2010<jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content> were not related to disease outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Serum <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20108 and <jats:styled-content style=\"fixed-case\">sCD<\/jats:styled-content>14 levels before <jats:styled-content style=\"fixed-case\">UDCA<\/jats:styled-content> therapy represent noninvasive surrogate markers of prognosis in patients with <jats:styled-content style=\"fixed-case\">PBC<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.13316","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T13:32:44Z","timestamp":1479389564000},"page":"897-905","source":"Crossref","is-referenced-by-count":24,"title":["Association between serum soluble <scp>CD<\/scp>14 and <scp>IL<\/scp>\u20108 levels and clinical outcome in primary biliary cholangitis"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-919X","authenticated-orcid":false,"given":"Takeji","family":"Umemura","sequence":"first","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Joshita","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Fujimori","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Shibata","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiharu","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakera","family":"Shums","sequence":"additional","affiliation":[{"name":"Inova Diagnostics  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8992-1866","authenticated-orcid":false,"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[{"name":"Inova Diagnostics  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Gastroenterology Department of Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine Shinshu University School of Medicine  Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61965-4"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20907"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.03.017"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24705"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.08.010"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92034-5"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/jama.1997.03550220152020","article-title":"Immunopathogenesis of gastrointestinal and hepatobiliary diseases","volume":"278","author":"Galperin C","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22653"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50446"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00501-4"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20788"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.4.586"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.022"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.063"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22428"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.003"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.216"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.031"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28017"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20859"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021381"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074225"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2013.0075"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.118"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21172"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21472"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22906"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21700"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/003591576706001205"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq165"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00802.x"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1869"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052723"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2007.01465.x"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq118"},{"key":"e_1_2_9_39_1","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4049\/jimmunol.147.5.1567","article-title":"Shedding as a mechanism of down\u2010modulation of CD14 on stimulated human monocytes","volume":"147","author":"Bazil V","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.5.1762-1769.1996"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.3.1135-1141.1998"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01254.x"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26319"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.01.020"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28356"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28572"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13316","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13316","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.13316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:27:57Z","timestamp":1695504477000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.13316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1111\/liv.13316"],"URL":"https:\/\/doi.org\/10.1111\/liv.13316","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,6]]}}}